Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Host Factors in Patients With Monoclonal Gammopathies and Other Hematologic Disorders

NCT05312255 is registered in ClinicalTrials.gov with Roswell Park Cancer Institute as lead sponsor.

NCT NCT05312255
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05312255 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Host Factors in Patients With Monoclonal Gammopathies and Other Hematologic Disorders
Lead sponsor
Roswell Park Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
June 28, 2022
Completion date
June 28, 2027
Enrollment
175 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

plasma cell myeloma, recurrent plasma cell myeloma, refractory plasma cell myeloma, smoldering plasma cell myeloma